ES464412A1 - Un procedimiento para la preparacion de cefazolina sodica, esencialmente cristalina y rapidamente soluble. - Google Patents
Un procedimiento para la preparacion de cefazolina sodica, esencialmente cristalina y rapidamente soluble.Info
- Publication number
- ES464412A1 ES464412A1 ES464412A ES464412A ES464412A1 ES 464412 A1 ES464412 A1 ES 464412A1 ES 464412 A ES464412 A ES 464412A ES 464412 A ES464412 A ES 464412A ES 464412 A1 ES464412 A1 ES 464412A1
- Authority
- ES
- Spain
- Prior art keywords
- cefazolin sodium
- parenteral administration
- preparing
- rapidly dissolving
- dissolving powder
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- 229960003408 cefazolin sodium Drugs 0.000 title abstract 3
- FLKYBGKDCCEQQM-WYUVZMMLSA-M cefazolin sodium Chemical compound [Na+].S1C(C)=NN=C1SCC1=C(C([O-])=O)N2C(=O)[C@@H](NC(=O)CN3N=NN=C3)[C@H]2SC1 FLKYBGKDCCEQQM-WYUVZMMLSA-M 0.000 title abstract 3
- 238000000034 method Methods 0.000 title abstract 2
- 238000007911 parenteral administration Methods 0.000 title abstract 2
- 239000000843 powder Substances 0.000 title abstract 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 abstract 1
- 238000004108 freeze drying Methods 0.000 abstract 1
- 239000008024 pharmaceutical diluent Substances 0.000 abstract 1
- 239000002904 solvent Substances 0.000 abstract 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
- A61K31/542—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
- A61K31/545—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Cephalosporin Compounds (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Un procedimiento para la preparación de cefazolina sódica esencialmente cristalina y rápidamente solublecaracterizado por las siguientes operaciones:a) enfriar lentamente una solución que contiene cefazolina sódica en un disolvente constituido por 2 a 25% de un alcanol C1-C3 y 75 a 98% (v/v) de aguadurante un periodo de 3 a 12 horashasta -10ºC;b) continuar enfriando el preparado de a) hasta que la mezcla ha solidificado por completo;c) reducir la presión del ambiente en el que se mantiene el preparado de b) hasta 1 mm absoluto de mercurio como máximo;d) elevar la temperatura del ambiente en el que se mantiene el preparado de c) hasta 50ºC como máximoevitando la fusión de dicho preparado ye) sublimar el disolvente del preparado de d) hasta que los cristales de cefazolina sódica resultantes presentan un contenido en humedad no superior al 60% y un contenido en alcanol no superior al 10% (p/p).
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US74455276A | 1976-11-24 | 1976-11-24 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ES464412A1 true ES464412A1 (es) | 1978-09-01 |
Family
ID=24993135
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ES464412A Expired ES464412A1 (es) | 1976-11-24 | 1977-11-23 | Un procedimiento para la preparacion de cefazolina sodica, esencialmente cristalina y rapidamente soluble. |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US4146971A (es) |
| JP (1) | JPS6019758B2 (es) |
| BE (1) | BE861134A (es) |
| CA (1) | CA1097341A (es) |
| DD (1) | DD136967A5 (es) |
| DE (1) | DE2752443C2 (es) |
| ES (1) | ES464412A1 (es) |
| FR (1) | FR2372168A1 (es) |
| GB (1) | GB1589316A (es) |
| IE (1) | IE45994B1 (es) |
| IL (1) | IL53427A0 (es) |
| NL (1) | NL189357C (es) |
Families Citing this family (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS5726692A (en) * | 1980-07-22 | 1982-02-12 | Fujisawa Pharmaceut Co Ltd | Preparation of stable crystal of salt of ceftizoxime |
| US4458070A (en) * | 1982-07-19 | 1984-07-03 | Pfizer Inc. | Process for the manufacture of crystalline sodium cefoperazone |
| US4456753A (en) * | 1983-02-07 | 1984-06-26 | Pfizer Inc. | Process for the manufacture of highly crystalline sodium cefoperazone |
| FR2561916B1 (fr) * | 1984-03-30 | 1987-12-11 | Lafon Labor | Forme galenique pour administration orale et son procede de preparation par lyophilisation d'une emission huile dans eau |
| JPS60255723A (ja) * | 1984-05-31 | 1985-12-17 | Ono Pharmaceut Co Ltd | メシル酸ガベキサートの結晶性凍結乾燥製剤及びその製造方法 |
| DE3911321A1 (de) * | 1989-04-07 | 1990-10-11 | Hoechst Ag | Verfahren zur herstellung von cefazolin-natriumsalz |
| TW264475B (es) * | 1991-09-20 | 1995-12-01 | Takeda Pharm Industry Co Ltd | |
| JPH06122630A (ja) * | 1992-10-12 | 1994-05-06 | Taiyo Yakuhin Kogyo Kk | 安定な塩酸セフォチアム製剤 |
| EP0758651B1 (en) * | 1994-05-02 | 2002-09-11 | Shionogi & Co., Ltd. | Crystal of pyrrolidylthiocarbapenem derivative, lyophilized preparation containing said crystal, and process for producing the same |
| RU2244716C1 (ru) * | 2003-06-27 | 2005-01-20 | Савельев Евгений Александрович | Способ получения натриевой соли 7-(1-н-тетразол-1-ил)-ацетамидо-3-(2-метил-1,3,4-тиадиазол-5-ил)тиометил)- 3-цефем-4-карбоновой кислоты(цефазолина) |
| WO2007041156A2 (en) | 2005-09-29 | 2007-04-12 | Nektar Therapeutics | Antibiotic formulations, unit doses, kits, and methods |
| CN100391961C (zh) * | 2005-11-16 | 2008-06-04 | 天津大学 | 五水头孢唑林钠晶体结构及晶体分子组装制备方法 |
| EP1870649A1 (en) | 2006-06-20 | 2007-12-26 | Octapharma AG | Lyophilisation targetting defined residual moisture by limited desorption energy levels |
| CN103751123A (zh) * | 2014-01-22 | 2014-04-30 | 邓学峰 | 一种头孢唑林的组合药物 |
| CN103965215B (zh) * | 2014-04-30 | 2016-04-27 | 悦康药业集团有限公司 | 一种头孢唑林钠化合物及其无菌粉针 |
| CN104530087B (zh) * | 2014-12-25 | 2017-07-21 | 天津大学 | 一种头孢唑林钠新晶型及其制备方法 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3449885A (en) * | 1966-03-31 | 1969-06-17 | Ben Venue Lab Inc | Method of packaging viral antisera and other research diagnostic reagents |
| DE2362785A1 (de) * | 1973-12-18 | 1975-06-26 | Atmos Fritzsching & Co Gmbh | Verfahren zum haltbarmachen von kristallsuspensionen |
| US4029655A (en) * | 1975-04-11 | 1977-06-14 | Eli Lilly And Company | Method of preparing stable sterile crystalline cephalosporins for parenteral administration |
-
1977
- 1977-11-20 IL IL53427A patent/IL53427A0/xx not_active IP Right Cessation
- 1977-11-21 NL NLAANVRAGE7712823,A patent/NL189357C/xx not_active IP Right Cessation
- 1977-11-23 ES ES464412A patent/ES464412A1/es not_active Expired
- 1977-11-24 BE BE1008537A patent/BE861134A/xx not_active IP Right Cessation
- 1977-11-24 DE DE2752443A patent/DE2752443C2/de not_active Expired
- 1977-11-24 GB GB48915/77A patent/GB1589316A/en not_active Expired
- 1977-11-24 IE IE2379/77A patent/IE45994B1/en not_active IP Right Cessation
- 1977-11-24 DD DD77202233A patent/DD136967A5/xx not_active IP Right Cessation
- 1977-11-24 FR FR7735429A patent/FR2372168A1/fr active Granted
- 1977-11-24 JP JP52141435A patent/JPS6019758B2/ja not_active Expired
- 1977-11-24 CA CA291,616A patent/CA1097341A/en not_active Expired
- 1977-12-14 US US05/860,365 patent/US4146971A/en not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| IL53427A0 (en) | 1978-01-31 |
| JPS5369821A (en) | 1978-06-21 |
| DE2752443C2 (de) | 1983-07-14 |
| US4146971A (en) | 1979-04-03 |
| FR2372168A1 (fr) | 1978-06-23 |
| NL189357C (nl) | 1993-03-16 |
| GB1589316A (en) | 1981-05-13 |
| FR2372168B1 (es) | 1980-11-14 |
| JPS6019758B2 (ja) | 1985-05-17 |
| CA1097341A (en) | 1981-03-10 |
| DD136967A5 (de) | 1979-08-08 |
| BE861134A (fr) | 1978-05-24 |
| DE2752443A1 (de) | 1978-06-01 |
| NL7712823A (nl) | 1978-05-26 |
| IE45994B1 (en) | 1983-01-26 |
| IE45994L (en) | 1978-05-24 |
| NL189357B (nl) | 1992-10-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IE45994L (en) | Preparing crystalline cefazolin sodium by solvent¹sublimation. | |
| ES446906A1 (es) | Un metodo de preparacion de cefalotina sodica, cefaloridin- betaina y cefazolina sodica, esteriles y esencialmente cris-talinas. | |
| IL63304A0 (en) | Porous,powder-form polypropylene,its production and its use | |
| ES2183874T3 (es) | Cristal derivado de pirrolidylthiocarbapenem, preparado liofilizado conteniendo dicho cristal y procedimiento para su produccion. | |
| JPH05271241A (ja) | 結晶の製法 | |
| ES2049833T3 (es) | Procedimiento para la preparacion de cristales de sulfuro sodico anhidro. | |
| US2585239A (en) | Amine salt of penicillin | |
| HUT53117A (en) | Process for producing n-acetylneuraminic acid-sodium salt-trihydrate | |
| ES455069A1 (es) | Un procedimiento para la preparacion de una cefazolina sodi-ca esencialmente amorfa, esteril, para su reconstitucion para la administracion parenteral. | |
| US3539550A (en) | Process for the preparation of 2'-halo-2'-deoxy pyrimidine nucleosides | |
| US2993833A (en) | Erythromycin esters | |
| US2802864A (en) | Higher alkyl amine salts of glutamic acid | |
| CA1138866A (en) | Chemical process for preparing isoxazolo-benzoxazinone derivatives | |
| GB1211625A (en) | Process for the production of n-carboxy anhydrides of amino acids and derivatives thereof | |
| US3708478A (en) | A crystalline complex of cephaloridine with an alkane diol | |
| US4132848A (en) | Method of preparing a rapidly dissolving powder of crystalline cephalothin sodium for parenteral administration | |
| JPS6019759B2 (ja) | 非経口投予用11115152139199東京都中央区京橋2丁目3番13号 | |
| US4226769A (en) | Process for preparing a solid preparation of a penicillin derivative | |
| JPS5446722A (en) | Novel preparation of s-2-(3-aminopropyl-amino) ethyldihydrogenphosphorothioate monohydrate crystal | |
| US3213102A (en) | 6-imidopenicillanic acids | |
| Hann et al. | Aldehydo Derivatives of d-[α-Galaheptose] | |
| US2721193A (en) | Penicillin salt of n-(beta-chloro-beta-phenethyl)-piperidine | |
| US2682538A (en) | Penicillin salt of alpha-phenyl-beta-morpholinoethyl alpha-chloroacetate | |
| Crichton | CLXVIII.—Hydrates of some quaternary bases | |
| US3888916A (en) | Amantadine salt of 16,16-dimethyl-pge' 2 |